Neurologic Disorders Resource Center

Click on the subcategory below to find drug monographs for that particular area.

Depression Risk, Parkinson's Disease

Untreated patients in the early stages of Parkinson's disease are more likely to experience neuropsychiatric symptoms such as depression.

Child Neurodevelopment Disability Up

There has been a 20.9% increase in child disability cases related to any neurodevelopment or mental health condition since 2001.

Cognitive Function and Stroke Risk

Lower cognitive function is associated with increased risk of stroke in older adults, and cognitive decline increases after stroke vs. before stroke.

Wearable Cameras Help with Memory

Wearable cameras could help in both event recall and improvement to brain functioning and memory in patients with amnesia and dementia.

Fish Once-a-Week and Cognitive Decline

It may only take eating one portion of fish once a week to gain protective benefits against cognitive decline, including Alzheimer’s disease.

HIV Linked to Lower MS Risk

HIV infection is associated with a significantly decreased risk of developing multiple sclerosis (MS).

Vitamin D and Alzheimer's Disease

Low concentrations of serum 25-hydroxyvitamin D (25[OH]D) may increase the risk of developing all-cause dementia and Alzheimer's disease.

Chart: Multiple Sclerosis Treatments

Review this new chart on multiple sclerosis treatments for quick information when you need it.

Videos

News

Alzheimer's ID'ed with CSF Biomarkers, Independent of APOE Genotype

Cerebrospinal fluid (CSF) biomarkers for Alzheimer's disease (AD), particularly β-amyloid 42 (Aβ42), are strongly associated with AD diagnosis, independent of APOE genotype.

Does Age Impact Deep Brain Stimulation Complications?

For patients with Parkinson's disease undergoing deep brain stimulation (DBS), increasing age does not impact complication rates.

New Multiple Sclerosis Treatment Safe in Early Trials

A new monoclonal antibody treatment for multiple sclerosis (MS) is safe, according to a phase I trial.

Stiff Person Syndrome: Remission with Stem Cells

For patients with stiff person syndrome (SPS), autologous hematopoietic stem cell transplantation (auto-HSCT) can induce prolonged clinical remission.

FEATURES

Alzheimer's ID'ed with CSF Biomarkers, Independent of APOE Genotype

Alzheimer's ID'ed with CSF Biomarkers, Independent of APOE Genotype

Cerebrospinal fluid (CSF) biomarkers for Alzheimer's disease (AD), particularly β-amyloid 42 (Aβ42), are strongly associated with AD diagnosis, independent of APOE genotype.

Does Age Impact Deep Brain Stimulation Complications?

Does Age Impact Deep Brain Stimulation Complications?

For patients with Parkinson's disease undergoing deep brain stimulation (DBS), increasing age does not impact complication rates.

New Multiple Sclerosis Treatment Safe in Early Trials

New Multiple Sclerosis Treatment Safe in Early Trials

A new monoclonal antibody treatment for multiple sclerosis (MS) is safe, according to a phase I trial.

Featured courses from mycme

UCLA Review of Clinical NeurologyExternal web site

Led by Course Chair Alon Avidan, MD, MPH, the authoritative faculty of The UCLA Review ...

CME 23.00 Credits

Hallucinations - Red flag symptomsExternal web site

Hallucinations - Red flag symptoms

0.50 Credits

Clinical review - StrokeExternal web site

Clinical review - Stroke

2.50 Credits

Sign Up for Free e-newsletters